ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHA4 | EPH receptor A4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EPHA6 | EPH receptor A6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGR | FGR proto-oncogene, Src family tyrosine kinase | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FRK | Fyn-related Src family tyrosine kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FYN | FYN proto-oncogene, Src family tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LMTK2 | Lemur tyrosine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PTK2 | Protein tyrosine kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PTK2B | Protein tyrosine kinase 2 beta | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PTK6 | Protein tyrosine kinase 6 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
SYK | Spleen tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
TNK2 | Tyrosine kinase, non-receptor, 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
YES1 | YES proto-oncogene 1, Src family tyrosine kinase | Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |